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Short running head: Open vs Lap resection for Stage IV CRC 
Mini Abstract 
Short- and long-term outcomes of laparoscopic and open resection for incurable Stage IV 
colorectal cancer were examined in a large cohort study. The effectiveness of laparoscopic 




Objective: To investigate the hypothesis that laparoscopic primary tumor resection is 
safe and effective when compared with the open approach for colorectal cancer patients 
with incurable metastases.  
Summary and Background Data: There are only a few reports with small numbers 
of patients on laparoscopic tumor resection for Stage IV colorectal cancer. 
Methods: Data from consecutive patients who underwent palliative primary tumor 
resection for Stage IV colorectal cancer between January 2006 and December 2007 were 
collected retrospectively from 41 institutions. Short- and long-term outcomes were 
compared between patients who underwent laparoscopic or open resection. 
Results: A total of 904 patients (laparoscopic group: 226, open group: 678) with a median 
age of 64 years (range: 22-95) were included in the analysis. Conversion was required in 
28 patients (12.4%) and most of the reasons for conversion (23/28: 82%) were bulky or 
invasive tumors. There was no 30-day postoperative mortality in either group. The 
complication rate (NCI-CTCAE Grade 2-4) after laparoscopic surgery (17%) was 
significantly lower than that after open surgery (24%) (P=0.02), and the difference was 
greater (4% vs. 12%; P<0.001) when we limited the analysis to severe (≧Grade 3) 
complications. The median length of postoperative hospital stay in the laparoscopic group 
was significantly shorter than that in the open group (14 vs. 17 days; P=0.002). In univariate 
analysis, overall survival for the laparoscopic group was significantly better than that for 
open surgery (Median survival time: 25.9 vs. 22.3 months, P=0.04), although no difference 
was apparent in multivariate analysis. 
Conclusions: Laparoscopic primary tumor resection has advantages in the short term 
and no disadvantages in the long term, compared with open surgery. It is a reasonable 




Colorectal cancer is one of the most common neoplasms worldwide 1. 
Approximately 20 to 25% of patients with colorectal cancer are reported to have metastatic 
disease at the time of first presentation 2, 3. Of these, only about 20% of patients can 
undergo curative resection of the distant metastasis 4. 
There are two controversies surrounding the treatment strategy for incurable Stage 
IV colorectal cancer. The first is whether or not we should remove the primary tumor in 
patients with incurable metastases. With the progress of chemotherapy for colorectal 
cancer in the last two decades, non-operative treatment has become one of the important 
treatment options for incurable Stage IV colorectal cancer 5-7. Based on this opinion, 
National Cancer Network (NCCN) guidelines recommend non-operative treatment for 
incurable Stage IV colorectal cancer without symptoms 8. On the other hand, some reports 
advocate the benefits of primary tumor resection as a treatment for Stage IV colorectal 
cancer 3, 9, 10. Therefore there seems to be no consensus at this time regarding the 
effectiveness of palliative primary tumor resection for incurable Stage IV patients.   
The second controversy is whether, if the primary tumor is to be resected, we 
should use an open or laparoscopic approach. The role of laparoscopic primary tumor 
resection for incurable Stage IV colorectal cancer has not been well evaluated, although 
randomized control trials have confirmed the feasibility and efficacy of laparoscopic surgery 
for localized colorectal cancer 11-14. There have been several reports demonstrating the 
efficacy of the laparoscopic approach for Stage IV colorectal cancer compared to Stage I-III 
disease 15, 16, or to open surgery 4, 17, in terms of complication rate, hospital stay, or even 
survival time. However, these studies included relatively small numbers of patients and the 
evidence is limited and inconclusive. 
Thus, in order to clarify the role of laparoscopic primary tumor resection in the 
treatment of Stage IV colorectal cancer, we conducted this multicenter observational study 
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including a large number of patients to compare the short- and long-term outcomes 
between open and laparoscopic primary tumor resection for exclusively “incurable” Stage 
IV colorectal cancer. 
  
Patients and Methods 
Patients with incurable Stage IV colorectal cancer who underwent primary tumor 
resection at 41 institutions participating in the Japan Society of Laparoscopic Colorectal 
Surgery from January 2006 to December 2007 were included in this study. All the surgeons 
were experienced and skilled in open surgery and had experience of more than 100 open 
surgery cases, and most of the surgeons (32/38) had experience of more than 100 
laparoscopic colorectal surgeries. Four surgeons had performed less than 30 laparoscopic 
colorectal surgeries and 2 of these performed only open surgeries in this study. This study 
included only patients who underwent “palliative” primary tumor resection and excluded 
those who underwent resection of metastases with curative intent, irrespective of whether 
this was simultaneous or two-stage. The choice of operative approach (open or 
laparoscopic) was at the surgeon’s discretion. According to a questionnaire requesting 
information on treatment strategies for incurable Stage IV colorectal cancer from each 
institute participating in this study, the first choice of treatment was systemic chemotherapy 
in 11, open resection in 4, laparoscopic resection in 3 and in the remaining 23 institutes, the 
treatment selection depended on the patients’ condition. After approval of each institution’s 
ethical committee, the consecutive patients’ demographic and clinicopathological data 
including operating time, blood loss, conversion, intraoperative complications, residual 
tumor sites, chemo/radiotherapy, tumor pathology, length of hospital stay, postoperative 
complications, and survival times were collected retrospectively. Tumor location was 
defined according to the Japanese Classification of Colorectal Carcinoma Second English 
Edition 18. “Tumor stenosis” was defined as the condition where colonoscopy could not 
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pass through the tumor region.   
The primary endpoint was overall survival. Secondary endpoints included length of 
hospital stay, oral intake on the day after the operation, increment of C-reactive protein 
(CRP) and increment of white blood cell count (WBC) on the first postoperative day, 
complication rate, and postoperative febrile period.  
The sample size required for calculating 2-year overall survival with adequate 
accuracy was estimated as 600 using imaginary data (imaginary 2-year survival: 20%).   
 
Statistical Analysis 
Overall survival was calculated from the date of operation until death from any 
cause or the date of the last follow-up. Survival curves were estimated using 
Kaplan-Meier’s method, and comparison was performed with a log-rank test. Factors 
related to survival were analyzed with the Cox proportional hazards regression model for 
multivariate analysis. Categorical variables were compared with Fisher’s exact test. 
Continuous variables were compared using t-tests. All P values were two-sided and P 
values less than 0.05 were considered statistically significant. All analyses were performed 
using SAS version 9.2 (SAS Institute, Cary, NC). 
 
Results 
During the study period, data from 972 patients were collected. Nine patients were 
excluded from analysis because of the exclusion criteria. Emergency operation was carried 
out in 59 patients. Most of the emergency operations except one case were open 
resections, and they were also excluded from the analysis set to reduce bias between the 
groups. Thus, a total of 904 patients were used for analysis. Of these, laparoscopic 
resection was performed in 226 cases (laparoscopic group), and open resection was 
performed in 678 cases (open group).     
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Patient clinicopathological characteristics in both groups are shown in Tables 1 and 
2. There was no difference between the groups in terms of age, American Society of 
Anesthesiologists (ASA) class, tumor location, and rate of tumor stenosis. The proportion of 
rectal cancer was similar between the two groups (open: 137/677 (20.2%), laparoscopic: 
42/226 (18.6%)). In this series, 412 (47%) patients had stenotic disease and 210 (23%) 
patients suffered from preoperative anemia (Hb <10.0). Twenty-eight cases (12.4%) of the 
laparoscopic resections needed conversion to open surgery. Most of the reasons for 
conversion (23/28: 82%) were bulky or invasive tumors. Six intraoperative complications 
including five cases of bleeding and one splenic injury were observed exclusively in the 
open group. Operative times were significantly longer in the laparoscopic group (222 vs. 
175 minutes; P=0.002). However, estimated blood loss was less in the laparoscopic group 
compared with the open group (50 vs. 180 g; P<0.001). The proportion of patients who had 
metastases involving multiple organ sites was higher in the open group than in the 
laparoscopic group (37.6% vs. 28%; P=0.008). 
Short-term outcomes are shown in Table 3. The laparoscopic group showed 
significantly lower white blood cell counts on the first postoperative day, earlier first oral 
intake, shorter periods of postoperative fever (≧37℃), and shorter lengths of postoperative 
hospital stay. Postoperative complications (NCI-CTCAE ver. 3.0 ≧Grade 2) occurred less 
frequently in the laparoscopic group (16.8%) compared with open resection (24.2%; 
P=0.02). When we limited analysis to severe complications (Grade 3 or 4), the difference 
became more obvious (4.4% vs. 11.9%; P<0.001). There was no 30-day mortality after 
operation in either group.   
The median follow-up time for all patients was 30 months. The median survival time 
of patients who underwent laparoscopic surgery (25.9 months) was significantly longer than 
that for open surgery (22.3 months; P=0.04) (Figure 1). The proportions of patients who 
underwent chemotherapy after laparoscopic and open surgery were 85% and 82% 
6 
 
respectively, and median lengths of the initiation of chemotherapy after operation were 28 
(range: 6-753) and 33 (range: 8-746) days respectively. In multivariate analysis using the 
Cox regression hazard model, ASA class, age, Carcinoembryonic antigen (CEA) level, and 
number of metastatic organs had a significant impact on overall survival. Overall survival for 
the laparoscopic approach was not inferior to that for the open approach even by 
adjustment of these covariates (Hazard Ratio (HR): 0.91; P=0.37) (Table 4). 
 
Discussion 
Approximately 20 to 25% of patients diagnosed with colorectal cancer have 
synchronous metastasis (Stage IV) at the time of first presentation 2, 3. These patients 
generally have a poor prognosis, unless all metastatic disease is removed completely. 
Unfortunately, the proportion of such patients is only around 20%, and the role of surgery 
for the majority of Stage IV patients still remains palliative 4. 
For patients with synchronous “incurable” metastases, it is generally accepted that 
the primary tumor should be removed, if possible, when it is causing symptoms, i.e., 
stenosis or bleeding. However, it is controversial whether or not primary tumors should be 
removed in the absence of symptoms. Non-operative treatment including systemic 
chemotherapy is recommended by the NCCN guidelines 8 as a first treatment for incurable 
Stage IV colorectal cancer without symptoms. This is based on the opinion that, with the 
advancement of systemic chemotherapy, primary tumor resection is not necessary for most 
patients without symptoms at their first presentation 5, 19. Poultsides et al. 7 reported that the 
use of chemotherapy without tumor resection for asymptomatic disease is appropriate 
standard practice; however 11% of patients required intervention during the treatment. In 
contrast Cook et al. 3 reported using the SEER database that more than 60% of patients 
with Stage IV colorectal cancer in practice underwent primary tumor resection, and that 
their prognosis was better than that of patients without resection (median survival time 
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(MST) of colon cancer patients: 11 vs. 2 months; MST of rectal cancer patients: 16 vs. 6 
months). Ruo et al. also retrospectively investigated the outcomes of patients with 
asymptomatic Stage IV colorectal cancer who did or did not undergo palliative primary 
tumor resection 10. They demonstrated that the resection group showed a survival 
advantage compared with the non-resection group, although the number of distant 
metastatic sites involved and the volume of hepatic replacement by tumor was smaller in 
the resection group (MST 16 vs. 9 months). At this time, there is no conclusive evidence 
regarding the effectiveness of palliative primary tumor resection for incurable Stage IV 
patients. More than half of the patients in this study had stenotic disease or were anemic 
(Hb<10.0), and the results were similar with or without symptoms, though because we don’t 
have data on patients who were excluded from surgery, we cannot comment on the 
effectiveness of palliative primary tumor resection. We feel that the operative indications for 
incurable Stage IV patients may depend on various factors including the patient’s general 
condition, estimated life expectancy, local advancement of the primary tumor, and the 
invasiveness of surgery.   
 Laparoscopic surgery offers perioperative clinical benefits for patients with localized 
colon cancer compared with open surgery 11-14. However the evidence concerning its 
benefits as a treatment for Stage IV colorectal cancer is still lacking. There are several 
reports that advocate the use of laparoscopic resection for Stage IV colorectal cancer. Two 
reports comparing the surgical and/or oncological outcomes after laparoscopic colorectal 
resection, between localized disease (Stage I-III) and metastatic disease (Stage IV) 15, 16, 
demonstrated that laparoscopic surgery for selected Stage IV colorectal cancer can be 
successfully performed without increasing the incidence of complications, despite the 
inclusion of larger and more invasive tumors in the Stage IV group. Law analyzed the data 
from 200 colorectal cancer patients with metastases who underwent primary tumor 
resection (77 laparoscopic and 123 open resection), and reported that the survival times of 
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patients with laparoscopic and open resection were similar (MST: 16.0 vs. 16.4 months) 4. 
However, these studies were not conclusive due to their small sample size.   
In this study, we demonstrated the benefits of laparoscopic surgery over open 
surgery by analysis of data from 904 incurable Stage IV patients. Regarding safety, there 
was no 30-day operative mortality in this series. The frequency of postoperative 
complications in the laparoscopic group (16.8%) was low compared with the open group, 
and when we limited analysis to severe complications (≧Grade 3), the frequency was only 
4.4%. Although the definition of complication is somewhat different, this rate compares 
favorably with previous reports from other groups 4, 15. Interestingly, these complication 
rates are comparable to the previous report from the Japanese multicenter study of 
laparoscopic resection for Stage I-III colorectal cancer 20. Therefore, we feel that the 
laparoscopic approach is, if performed by an experienced surgeon, safe and feasible even 
for colorectal cancer patients with synchronous incurable metastases. On the other hand, 
the conversion rate of 12.6% in this series seems to be higher than that of around 4% in 
Kitano’s series 20. The major reason for conversion in this study was the presence of 
advanced tumor. Indeed, Moloo described the major factor associated with conversion in 
Stage IV patients to be tumor fixation, a different pattern from that seen in Stage I-III, and 
stated that this should influence decision-making when offering a laparoscopic resection for 
patients with Stage IV colorectal cancer 15, because conversion may negate the benefits of 
laparoscopic surgery 21. The length of postoperative hospital stay in the laparoscopic group 
was 14 days, significantly shorter than in the open group (17 days), but possibly somewhat 
longer than in previous reports from other countries; this may be due to differences in 
health insurance systems between Japan and other countries.   
Although overall survival time after laparoscopic resection was significantly longer 
than that after open resection in univariate analysis, the difference was no longer apparent 
when multivariate analysis was applied. This seems be due to the selection bias (e.g. the 
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proportion of patients with metastasis in only one organ was higher in the laparoscopic 
group). However, the results of multivariate survival analysis indicate that laparoscopic 
surgery produced at least equivalent long-term outcomes in comparison to open surgery. In 
previous studies of primary tumor resection for Stage IV colorectal cancer, survival 
outcomes were less favorable, and median survival time (MST) did not reach 20 months. In 
this series, in spite of including exclusively “incurable” metastatic colorectal cancer, the 
MST of both the open group (22.3 months) and the laparoscopic group (25.9 months) were 
much longer than those previously reported for similar patients undergoing operations for 
incurable cancer. We believe that the laparoscopic approach will enhance the benefits of 
primary tumor resection (i.e. reduction of tumor-associated complications induced by 
chemotherapy, including perforation or bleeding) without increasing the risk of surgery. 
This is a retrospective cohort study, and the choice of operative approach was at 
the surgeon’s discretion. Therefore, selection biases are the most important drawback of 
this type of study. A randomized controlled study would be ideal to confirm the efficacy of 
laparoscopic compared with open resection, though it seems difficult to balance the various 
factors involved in Stage IV patients. We believe this study may provide the best available 
evidence to determine the treatment strategy for incurable Stage IV colorectal cancer.  
 
Conclusion 
The laparoscopic approach has advantages in the short term and no disadvantages 
in the long term, compared with open surgery. Laparoscopic primary tumor resection is a 
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Figure 1. Long-term outcome: univariate analysis
Analysis set: patients undergoing surgery except for emergency ones




0 12 24 36 48 
Analysis set: patients undergoing surgery except for emergency ones
% %
Age Median 64 64
Range 26-95 22-87
Gender Male 403 59.5 114 50.4
Female 274 40.5 112 49.6
Height Median 160 160
Range 135-186 137-183
Weight Median 56 55
Range 29-120 33-85
ASA-PS "1/2" 618 92.0 211 94.2
"3/4" 53 8.0 13 5.8
Other neoplasms ≧1 26 3.8 7 3.1
none 652 96.2 219 96.9
Stenosis - 343 52.1 125 56.6
+ 316 48.0 96 43.4
Previous laparotomy + 151 22.7 67 30.2
- 513 77.3 155 69.8
Tumor location V/C/A/T 237 35.0 63 27.9
D/S/RS 298 44.0 120 53.1
other colon 99 5 0.7 1 0.4
Ra/Rb/P 137 20.2 42 18.6
total 677 100 226 100
Preoperative radiotherapy + 9 1.3 1 0.4
- 669 98.7 225 99.6
Preoperative chemotherapy + 45 6.6 10 4.4
- 633 93.4 216 95.6
CEA Median 24.5 28.7
Range 0.09-15927 1-19046
CA19-9 Median 41.0 29.8
Range 0.1-31410 0.1-113000
WBC Median 6780 6230
Range 690-23720 2300-14800
Hb Median 11.7 11.9
Range 5.1-17.4 5.0-16.5
CRP Median 0.6 0.3
Range 0-42.8 0-23.8




Surgery Right-sided colectomy 1 197 29.5 52 23.0 249 27.9 1
Left-sided colectomy 2 96 14.4 44 19.5 140 15.7
Transverse colectomy 3 30 4.5 9 4.0 39 4.4
Anterior resection 4 117 17.5 54 23.9 171 19.1
Low anterior resection 5 112 16.8 41 18.1 153 17.1
Abdominoperineal resection 6 34 5.1 11 4.9 45 5.0
Hartmann's procedure 7 73 10.9 11 4.9 84 9.4
Others 9 8 1.2 4 1.8 12 1.3
Open conversion + 28 12.4
- 198 87.6
Reason for Conversion Tumor invasion 23 82.2
Adhesion 2 7.1
Bleeding 1 3.6
Narrow view 2 7.1
Additional operation Liver resection 42 6.2 3 1.3 45 5.0
（複数回答可） Lung resection 0 0 0
Cholecystectomy 10 1.5 4 1.8 14 1.5
Small bowel resection 21 3.1 2 0.9 23 2.5
Other operations 107 15.8 20 8.8 127 14.0
- 522 77.0 200 88.5 722 79.9
Operative time (min) Median 175 222 188 3
Mean 207 234 214
Range 40-1220 63-650 40-1220
Bleeding（g） Median 180 50 134 8
Mean 329 126 278
Range 0-4800 0-3220 0-4800
Intraoperative complications + 6 0.9 0
Bleeding 5
spleen injury 1
- 672 99.1 226 100
fT M 1 0.1 0
SM 2 0.3 1 0.4
MP 25 3.7 4 1.8
SS 310 45.7 114 50.4
SE 214 31.6 72 31.9
SI 73 10.8 20 8.8
A 35 5.2 11 4.9
AI 18 2.7 4 1.8
fN 0 102 15.0 46 20.4 6
1 218 32.2 73 32.3
2 197 29.1 72 31.9
3 147 21.7 30 13.3
X 10 1.5 3 1.3
fM 0 380 56.0 127 56.2 9
1 290 42.8 98 43.4
Number of organs with residua  1 423 62.4 163 72.1
tumor ≧2 255 37.6 63 28
Table 2. Operative data




Analysis set: patients undergoing surgery except for emergency ones
% %
Postoperative WBC（/μl ）(1P Median 9600 8600 3
Mean 10001 9081 p<0.001
Range 2300-23200 1200-20100
Postoperative CRP（mg/dl） Median 6.9 5.2 58
Mean 8.5 6.1 p=0.19
Range 0-680 0.8-26.8
Water intake Median 3.0 1.0 14
Mean 3.4 2.2 p<0.001
Range 1-42 1-27
Afebrile date Median 4.0 3.0 42
Mean 4.8 4.0 p=0.02
Range 0-62 1-30
Longth of Stay Median 17 14 8
Mean 21 17 p=0.002
Range 1-142 6-77
Blood transfusion + 98 14.9 21 9.7 p=0.053 30
- 559 85.1 196 90.3
Postoperative complications (G  + 164 24.2 38 16.8 p=0.02
- 514 75.8 188 83.2
Postoperative complications (G  + 81 11.9 10 4.4 p<0.001
- 597 88.1 216 95.6
Postoperative complications (CTCAE Grade) Grade 2 Grade 3 Grade 4-5 Grade 2 Grade 3 Grade 4-5
Anastomotic leak # 8 16 4 5 3
Ileus # 17 25 1 6 1
Obstruction # 4 4 1 1
Wound infection # 35 8 13
Intra-abdominal infection # 8 4 1 1 2
Urinary dysfunction # 4 1 1
Bleeding # 1 1 1
Stroke # 2 1
Deep vein thrombosis # 1
Lung infection # 1 2 1
Others # 13 11 7 2 2
Multiple complications (cases) 16 2
P
Table 3. Short-term outcomes
Analysis set: patients undergoing surgery except for emergency ones




Factor Hazard Ratio 95%CI P
Approach laparo/open 0.91 0.89-1.36 p=0.37
ASA-PS 2/1 1.17 0.97-1.40 p<0.001
3/1 2.05 1.51-2.80
4/1 9.40 1.30-68.2
Age 70-79/＜70 1.17 1.17-1.74 p<0.001
≧80/＜70 1.62 1.62-3.00
CEA Q1/Q4 0.58 0.45-0.76 p<0.001
Q2/Q4 0.62 0.49-0.79
Q3/Q4 0.80 0.63-1.01
R2 organ 1/≧2 0.52 0.43-0.62 p<0.001
Table 4. Long-term outcome: multivariate analysis
Analysis set: patients undergoing surgery except for emergency ones
Open Versus Laparoscopic Resection of Primary Tumor for Incurable Stage IV 
Colorectal Cancer: A Large Multicenter Consecutive Patients Cohort Study 
Dear Sir/Madam 
We read with interest the article by Hida et al. published in the May 2012 issue of 
Annals of Surgery.1 We have discussed the paper in our journal club and would like to 
raise some points that we discussed. The choice of operation is subject to the surgeon’s 
discretion, which adds to the selection bias inherent in these studies. The fact that only 
one-fourth of the population under study were subject to laparoscopy leads one to 
presume that significant selection criteria were at play in influencing the surgical 
approach. These criteria could have been explored further; for example a survey of how 
surgeons decide between laparoscopic and open approaches could have provided 
valuable information to the reader. Factors such as nutritional state and presence of 
symptoms have not been compared between the two groups, raising the question if these 
factors played a role in decision making and have biased the results in favour of 
laparoscopic surgery. In studies of this kind, it is important for readers to have an 
insight into the overall picture. For example, what is the distribution of presentation (by 
stage) of all patients with colorectal cancer in the centres involved? How many patients 
with stage IV disease were seen in this period and what proportion of these had surgery? 
The paper reports a 12.4% conversion rate from laparoscopic to open approach. 
However it is not clear in which group these patients were analysed, specifically 
whether they were analysed by intention to treat. This number could make a significant 
difference to the results to either group. 
We noted the 0% 30-day mortality rates for both laparoscopic and open groups. This is 
extremely low for a cohort with such advanced disease undergoing major surgery. We 
wondered whether the in-hospital mortality rates was different, and whether that could 
have been reported alongside the 30-day mortality rates. 
Judith E Ritchie, MBChB MSc 
University of Sheffield 
Sheffield, South Yorkshire UNITED KINGDOM 
on behalf of Sheffield Surgical Journal Club 
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Reply to Letter: “Open Versus Laparoscopic Resection of Primary Tumor for 
Incurable Stage IV Colorectal Cancer: A Large Multicenter Consecutive Patients 
Cohort Study” 
 
Reply to Dr. Judith E Ritchie: 
 
We are pleased to have the opportunity to respond to the letter to the editor by 
Dr. Ritchie and would like to thank her and her journal club for their interest in our 
work. As Dr. Ritchie commented, the choice of operative approach was at the surgeon’s 
discretion, so selection bias is the most important drawback in this type of study. 
However, as the potential biases in the decision-making process for surgical 
management of stage IV colorectal cancer are diverse, even a randomized controlled 
study would likely not have been sufficient for balancing the various factors involved in 
stage IV patients.  
 In our study, we asked 41 institutions about their treatment strategy for stage IV 
incurable colorectal cancer. Eleven selected chemotherapy and 7 selected surgical 
resection as the first-line treatment, and the remaining 23 informed us that it depends on 
patient condition. Symptomatic cases were always indicated for surgery. Regarding the 
operative approach, 9 institutes considered open surgery as a first-line treatment, while 
16 considered laparoscopic surgery as a first-line treatment. 
 Although we did not compare nutritional state itself, we checked the factors 
representing the general condition of patients (height and weight, ASA physical status, 
and Hb levels). Concerning symptoms, we defined stenosis and anemia as 
tumor-derived symptoms
1
. Almost all patients with emergent disease received open 
surgery and were therefore excluded from our study, while other symptomatic patients 
who received laparoscopic surgery had better courses, as described in our other article
1
. 
The laparoscopic group included a 12.4% conversion and was analyzed by intention to 
treat. 
 Finally, we must apologize for an error in the mortality statistics; there were 
actually five 30-day mortalities in 678 open cases (0.7%) and one 30-day mortality in 
226 laparoscopic cases (0.4%).  
We hope that these data clarify the issues in question. 
 
Koya Hida, MD, PhD 
Suguru Hasegawa, MD, FACS, PhD 
Yoshiharu Sakai, MD, FACS, PhD 
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